School of Medicine
Showing 301-310 of 1,622 Results
-
Ananya Diwakant
Postdoctoral Scholar, General Internal Medicine
BioAnanya Diwakant is a Postdoctoral Scholar at Stanford University School of Medicine. Her current research focuses on evaluating the effects of health interventions, particularly the impact of shingles vaccination on dementia risk. Her methodological emphasis lies in causal inference and applied econometrics, using quasi-experimental research designs to identify causal effects in large-scale observational data.
Her broader research interests span health economics, development economics, and gender economics. Her doctoral research used experimental and quasi-experimental methods to examine how information, social norms, and social networks shape women's decision-making and access to economic opportunities in developing countries. More broadly, she is interested in developing and applying rigorous empirical methods to evaluate policies and interventions across a range of contexts. -
Igor D. Bandeira
Postdoctoral Scholar, Psychiatry
BioIgor D. Bandeira, M.D., Ph.D., is a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. With extensive experience in interventional psychiatry, Dr. Bandeira has led multiple clinical trials focused on noninvasive brain stimulation and rapid-acting antidepressants for psychiatric disorders in children, adolescents, and adults. He received the prestigious Professor Alfredo Thomé de Britto Award in recognition of his exceptional research achievements during his physician-scientist training at the Federal University of Bahia in Salvador, Brazil.
As part of his medical training, Dr. Bandeira also studied at the University of Sydney (Australia) on a Science Without Borders Scholarship, where he enhanced his clinical and research skills at the university’s Brain and Mind Centre. Upon returning to Brazil, he gained valuable clinical experience as an attending physician with the Brazilian Ministry of Health and worked on the frontlines during the COVID-19 pandemic.
At Stanford, working with Dr. Nolan R. Williams, Dr. Bandeira led the Wellcome LEAP trial on accelerated intermittent theta-burst stimulation (Stanford Neuromodulation Therapy) to treat anhedonic depression. Alongside Dr. Alan F. Schatzberg, he is co-leading a trial supported by the American Foundation for Suicide Prevention, evaluating the efficacy and safety of buprenorphine in sustaining the antisuicidal effects of ketamine. His work centers on developing personalized therapeutics for treatment-resistant depression, bipolar depression, and suicidal behavior.
Looking ahead, Dr. Bandeira plans to apply for psychiatry residency programs in the United States to advance his career in academic psychiatry and clinical research.